Production and purification of recombinant adeno-associated virus.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Methods in Enzymology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10800712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa

  1998cited by this paper
• Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

  1998cited by this paper
• Factors Influencing Recombinant Adeno-Associated Virus Production

  1998cited by this paper
• Packaging Cells Based on Inducible Gene Amplification for the Production of Adeno-Associated Virus Vectors

  1998cited by this paper
• Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors.

  1998cited by this paper
• Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors

  1998cited by this paper
• Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

  1997cited by this paper
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

  1997cited by this paper
• Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap

  1997cited by this paper
• Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in Muscle

  1997cited by this paper
• Recombinant adeno-associated virus for muscle directed gene therapy

  1997cited by this paper
• Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus.

  1997cited by this paper
• Role for highly regulated rep gene expression in adeno-associated virus vector production

  1997cited by this paper
• A New Strategy for Large-Scale Preparation of High-Titer Recombinant Adeno-Associated Virus Vectors by Using Packaging Cell Lines and Sulfonated Cellulose Column Chromatography

  1996cited by this paper
• A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

  1996cited by this paper
• Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

  1996cited by this paper
• Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

  1996cited by this paper
• Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus Vectors

  1996cited by this paper
• Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

  1996cited by this paper
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

  1996cited by this paper
• High-Efficiency Transfer of the T Cell Co-Stimulatory Molecule B7-2 to Lymphoid Cells Using High-Titer Recombinant Adeno-Associated Virus Vectors

  1995cited by this paper
• Cell Lines for the Production of Recombinant Adeno-Associated Virus

  1995cited by this paper
• Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding.

  1995cited by this paper
• Directional immobilization of heparin onto beaded supports.

  1994cited by this paper
• Adeno-associated virus vectors preferentially transduce cells in S phase.

  1994cited by this paper
• Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

  1993cited by this paper
• Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate.

  1992cited by this paper
• Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

  1989cited by this paper
• Adeno-associated virus general transduction vectors: analysis of proviral structures

  1988cited by this paper
• Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants

  1984cited by this paper
• Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.

  1984cited by this paper

• Neuroendocrine circuit for sleep-dependent growth hormone release.

  2025cites this paper
• The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3

  2024cites this paper
• Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome

  2024cites this paper
• Robotic manipulation of cardiomyocytes to identify gap junction modifiers for arrhythmogenic cardiomyopathy

  2024cites this paper
• Kir2.1 mutations differentially increase the risk of flecainide proarrhythmia in Andersen Tawil Syndrome

  2024cites this paper
• Extracellular cysteine disulfide bond break at Cys122 disrupts PIP2-dependent Kir2.1 channel function and leads to arrhythmias in Andersen-Tawil Syndrome

  2023cites this paper
• Circuit mechanism for suppression of frontal cortical ignition during NREM sleep.

  2023cites this paper
• p38γ/δ activation alters cardiac electrical activity and predisposes to ventricular arrhythmia

  2023cites this paper
• MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM)

  2023cites this paper
• circSnd1 promotes atherosclerosis progression through the miR-485-3p/Olr1 signaling pathway

  2023cites this paper
• Cardiovascular baroreflex circuit moonlights in sleep control.

  2022cites this paper
• Electrophoresis-Mediated Characterization of Full and Empty Adeno-Associated Virus Capsids

  2022cites this paper
• XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma

  2021cites this paper
• Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin

  2021cites this paper
• Dual Dysfunction of Kir2.1 Underlies Conduction and Excitation-Contraction Coupling Defects Promoting Arrhythmias in a Mouse Model of Andersen-Tawil Syndrome Type 1

  2021cites this paper
• Sustained Elevated Blood Pressure Accelerates Atherosclerosis Development in a Preclinical Model of Disease

  2021cites this paper
• XIAP Protects Retinal Ganglion Cells in the Mutant ND4 Mouse Model of Leber Hereditary Optic Neuropathy

  2020cites this paper
• Gene Therapy with Single-Subunit Yeast NADH-Ubiquinone Oxidoreductase (NDI1) Improves the Visual Function in Experimental Autoimmune Encephalomyelitis (EAE) Mice Model of Multiple Sclerosis (MS)

  2020cites this paper
• A common hub for sleep and motor control in the substantia nigra

  2020cites this paper
• Targeted Krüppel-Like Factor 4 Gene Knock-Out in Retinal Ganglion Cells Improves Visual Function in Multiple Sclerosis Mouse Model

  2020cites this paper
• Inhibition of impulsive action by projection-defined prefrontal pyramidal neurons

  2020cites this paper
• Targeting RyR2 with a phosphorylation site–specific nanobody reverses dysfunction of failing cardiomyocytes in rats

  2019cites this paper
• Control of Non-REM Sleep by Midbrain Neurotensinergic Neurons.

  2019cites this paper
• Sleep Regulation by Neurotensinergic Neurons in a Thalamo-Amygdala Circuit.

  2019cites this paper
• An Excitatory Circuit in the Perioculomotor Midbrain for Non-REM Sleep Control.

  2019cites this paper
• Pharmacological doses of melatonin impede cognitive decline in tau‐related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux

  2019cites this paper
• Cardiac adenovirus-associated viral Presenilin 1 gene delivery protects the left ventricular function of the heart via regulating RyR2 function in post-ischaemic heart failure

  2018cites this paper
• Targeting RyR2 with a phosphorylation site-specific nanobody Reverses Dysfunction of Failing Cardiomyocytes in Rat

  2018influential citation
• The Effects of XIAP Gene Therapy in a Murine Model of Leber’s Hereditary Optic Neuropathy and a Feline Model of Retinal Detachment

  2017cites this paper
• Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approach

  2017cites this paper
• Gene Therapy in a Large Animal Model of PDE6A-Retinitis Pigmentosa

  2017cites this paper
• Overexpression of the X-Linked Inhibitor of Apoptosis Protects Against Retinal Degeneration in a Feline Model of Retinal Detachment

  2017cites this paper
• miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.

  2016cites this paper
• Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration

  2016cites this paper
• Complex I subunit gene therapy with NDUFA6 ameliorates neurodegeneration in EAE.

  2015cites this paper
• Elevation of intraocular pressure in rodents using viral vectors targeting the trabecular meshwork.

  2015cites this paper
• Effects of antioxidant gene therapy on the development of diabetic retinopathy and the metabolic memory phenomenon

  2015cites this paper
• AAV-mediated lysophosphatidylcholine acyltransferase 1 (Lpcat1) gene replacement therapy rescues retinal degeneration in rd11 mice.

  2014cites this paper
• Inhibitor of Apoptosis-Stimulating Protein of p53 (iASPP) Is Required for Neuronal Survival after Axonal Injury

  2014cites this paper
• Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis.

  2014cites this paper
• AAV-mediated and pharmacological induction of Hsp70 expression stimulates survival of retinal ganglion cells following axonal injury

  2014cites this paper
• Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.

  2014cites this paper
• Chronic Knockdown of the Nucleus of the Solitary Tract AT1 Receptors Increases Blood Inflammatory-Endothelial Progenitor Cell Ratio and Exacerbates Hypertension in the Spontaneously Hypertensive Rat

  2013cites this paper
• Evaluation of Lateral Spread of Transgene Expression following Subretinal AAV–Mediated Gene Delivery in Dogs

  2013cites this paper
• S151A δ-sarcoglycan mutation causes a mild phenotype of cardiomyopathy in mice

  2013cites this paper
• Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.

  2013cites this paper
• Optimal delivery of therapeutic genes to pancreatic islets.

  2013cites this paper
• NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS.

  2013cites this paper
• Retinal angiogenesis suppression through small molecule activation of p53.

  2013cites this paper
• (Pro)renin Receptor Mediates Both Angiotensin II-Dependent and -Independent Oxidative Stress in Neuronal Cells

  2013cites this paper
• Effects on XIAP Retinal Detachment–Induced Photoreceptor Apoptosis

  2013cites this paper
• MicroRNA-34a regulates cardiac ageing and function

  2013cites this paper
• Synthetic riboswitches for external regulation of genes transferred by replication-deficient and oncolytic adenoviruses

  2012cites this paper
• Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology.

  2012cites this paper
• γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.

  2012cites this paper
• Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence-modified adeno-associated virus induces visual loss and optic atrophy in mice

  2012cites this paper
• Development and Validation of Novel AAV2 Random Libraries Displaying Peptides of Diverse Lengths and at Diverse Capsid Positions

  2012cites this paper
• Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber’s hereditary optic neuropathy in a mouse model

  2012cites this paper
• Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.

  2012cites this paper
• Long-Term Preservation of Cardiac Structure and Function After Adeno-Associated Virus Serotype 9-Mediated Microdystrophin Gene Transfer in mdx Mice

  2012cites this paper
• Effects of antioxidant gene therapy on retinal neurons and oxidative stress in a model of retinal ischemia/reperfusion.

  2012cites this paper
• Myokardialer Gentransfer mittels Adenoassoziierter Viraler Vektoren

  2012cites this paper
• Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors

  2011cites this paper
• Whirlin replacement restores the formation of the USH2 protein complex in whirlin knockout photoreceptors.

  2011cites this paper
• Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet-Biedl syndrome mouse model

  2011cites this paper
• Gene therapy rescues cone structure and function in the 3-month-old rd12 mouse: a model for midcourse RPE65 leber congenital amaurosis.

  2011cites this paper
• Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.

  2011cites this paper
• Involvement of the Brain (Pro)renin Receptor in Cardiovascular Homeostasis

  2010cites this paper
• Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.

  2010cites this paper
• Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency

  2010cites this paper
• The Inotropic Peptide (cid:1) ARKct Improves (cid:1) AR Responsiveness in Normal and Failing Cardiomyocytes Through G (cid:1)(cid:2) -Mediated L-Type Calcium Current Disinhibition

  2010cites this paper
• Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library

  2010cites this paper
• XIAP effects on retinal detachment-induced photoreceptor apoptosis [corrected].

  2009cites this paper
• Prevention of cardiomyopathy in d -sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors

  2009cites this paper
• A recombinant DNA and vaccinia virus prime–boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice

  2009cites this paper
• Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide Libraries

  2009cites this paper
• Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system.

  2009cites this paper
• Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.

  2009cites this paper
• Osteoclast polarization and orthodontic tooth movement.

  2009cites this paper
• Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.

  2009cites this paper
• AAV retinal transduction in a large animal model species: Comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector

  2009cites this paper
• Gene therapy targeting glaucoma: where are we?

  2009cites this paper
• Effect of CNTF on retinal ganglion cell survival in experimental glaucoma.

  2009cites this paper
• Efficient expression of self-complementary AAV in ganglion cells of the ex vivo primate retina

  2009cites this paper
• Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors

  2009cites this paper
• Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.

  2008cites this paper
• Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats

  2008cites this paper
• Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

  2008cites this paper
• Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential

  2008cites this paper
• Selection and characterization of targeted vector capsids from random adeno-associated virus type 2 (AAV-2) display peptide libraries

  2008cites this paper
• Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors

  2008cites this paper
• Characterization of a Bipartite Recombinant Adeno-Associated Viral Vector for Site-Specific Integration

  2007influential citation
• Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis

  2007cites this paper
• Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.

  2007cites this paper
• Brain-Derived Neurotrophic Factor Gene Transfer With Adeno-Associated Viral and Lentiviral Vectors Prevents Rubrospinal Neuronal Atrophy and Stimulates Regeneration-Associated Gene Expression After Acute Cervical Spinal Cord Injury

  2007cites this paper
• Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.

  2007cites this paper
• The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse.

  2007cites this paper
• Ocular drug delivery: molecules, cells, and genes.

  2007cites this paper
• XIAP Protection of Photoreceptors in Animal Models of Retinitis Pigmentosa

  2007cites this paper
• Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.

  2007cites this paper